Navigation Links
CareFusion Reports First Quarter Fiscal 2014 Results
Date:11/7/2013

$96 million, or $0.44 per diluted share.

During the quarter, CareFusion settled a previously disclosed tax matter with the IRS, which resulted in an adjusted effective tax rate of 21.4 percent and contributed approximately $0.04 per diluted share to the company's first quarter results.Medical SystemsFirst quarter revenue for the Medical Systems segment was $524 million, a 5 percent decrease from the prior year period on a reported and constant currency basis. Strong performance in the Infusion Systems business line was offset by declines in the Respiratory Technologies and Dispensing Technologies business lines.  

Segment profit for the quarter fell to $74 million from $102 million in the prior year period, a 27 percent decrease driven by expected lower volumes in the Dispensing Technologies business line resulting from a product line transition. Adjusted segment profit declined 20 percent to $90 million.

Procedural SolutionsStrong performance across the Procedural Solutions segment led to first quarter revenue of $306 million, a 7 percent increase from the prior year period on a reported and constant currency basis. Segment growth was led by double-digit revenue increases in both the Medical Specialties and Specialty Disposables business lines.  

Segment profit totaled $42 million, driven by gross margin improvements that were partially offset by increased investments in R&D. On an adjusted basis, segment profit grew 8 percent to $52 million.

Recent HighlightsAdditional first quarter and recent highlights included:

  • Completing the acquisition of Sendal, an infusion specialty disposable manufacturer in Spain that primarily serves the western European market, further expanding the company's Infection Prevention business line globally.
  • Investing $121 million to repurchase 3.3 million shares during the quarter under a two-year, $750 million

  • SOURCE CareFusion Corp.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

    Related medicine technology :

    1. CareFusion to Sell Neurodiagnostic Business to Natus Medical for $58 Million
    2. CareFusion Strengthens U.K. Presence With Acquisition of Medical Products Distributor
    3. CareFusion Expands Infusion Pump Interoperability
    4. CareFusion To Report Fourth Quarter And Fiscal 2012 Results On Aug. 9
    5. CareFusion Reports Fourth Quarter and Fiscal 2012 Results
    6. CareFusion Recognizes Best Of The Best U.S. Hospitals
    7. CareFusion Provides Update On Form 10-K Filing
    8. CareFusion To Report Preliminary Fiscal 2013 First Quarter Results On Nov. 8
    9. CareFusion Reports Preliminary First Quarter Fiscal 2013 Results
    10. CareFusion Launches New Preoperative Cleansing Program For In-Home Patient Use
    11. CareFusion Files Fiscal 2012 Form 10-K
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/24/2014)... MONROVIA, Calif. , July 24, 2014  Xencor, ... company developing engineered monoclonal antibodies for the treatment of ... that it will release second quarter financial results after ... will host a webcast and conference call the same ... discuss the financial results and provide a corporate update. ...
    (Date:7/24/2014)... , July 24, 2014 MedVantx, Inc., ... direct-to-consumer prescription delivery channel in physician offices, MedStart ... underlying issues related to medication non-adherence and hospital ... a recent issue of the Annals of ... researchers reported that frequent changes in generic medication ...
    (Date:7/24/2014)... , Second-quarter 2014 revenue declined 17 percent driven ... and Evista, partially offset by volume growth in several ... resulted in 11 percent OPEX reduction, partially offsetting revenue ... share were $0.68 on both a reported and non-GAAP ... with Immunocore in third quarter causes 2014 reported EPS ...
    Breaking Medicine Technology:Xencor to Host Second Quarter 2014 Financial Results Webcast and Conference Call 2Medication Non-Adherence Issue Highlighted in Annals of Internal Medicine Study Could Be Eliminated by a New Direct-to-Consumer Delivery Channel Ensuring Consistent Medication Appearance 2Medication Non-Adherence Issue Highlighted in Annals of Internal Medicine Study Could Be Eliminated by a New Direct-to-Consumer Delivery Channel Ensuring Consistent Medication Appearance 3Lilly Reports Second-Quarter 2014 Results 2Lilly Reports Second-Quarter 2014 Results 3Lilly Reports Second-Quarter 2014 Results 4Lilly Reports Second-Quarter 2014 Results 5Lilly Reports Second-Quarter 2014 Results 6Lilly Reports Second-Quarter 2014 Results 7Lilly Reports Second-Quarter 2014 Results 8Lilly Reports Second-Quarter 2014 Results 9Lilly Reports Second-Quarter 2014 Results 10Lilly Reports Second-Quarter 2014 Results 11Lilly Reports Second-Quarter 2014 Results 12Lilly Reports Second-Quarter 2014 Results 13Lilly Reports Second-Quarter 2014 Results 14Lilly Reports Second-Quarter 2014 Results 15Lilly Reports Second-Quarter 2014 Results 16Lilly Reports Second-Quarter 2014 Results 17Lilly Reports Second-Quarter 2014 Results 18Lilly Reports Second-Quarter 2014 Results 19Lilly Reports Second-Quarter 2014 Results 20Lilly Reports Second-Quarter 2014 Results 21Lilly Reports Second-Quarter 2014 Results 22Lilly Reports Second-Quarter 2014 Results 23Lilly Reports Second-Quarter 2014 Results 24
    ... Eli Lilly and Company (NYSE: LLY ) ... today presented an $11.6 million check to the United ... employees and retirees and a matching gift amount from ... Central Indiana chapter and other United Way chapters, 2010 ...
    ... Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... of Directors (the "Board") has declared a one-time special ... that shareholders of record as of the close of ... be entitled to receive on December 22, 2010.  The ...
    Cached Medicine Technology:Lilly Surpasses United Way 2010 Campaign Goal 2Valeant Declares Special Dividend and Plans to Create a Special Dividend Reinvestment Plan 2Valeant Declares Special Dividend and Plans to Create a Special Dividend Reinvestment Plan 3Valeant Declares Special Dividend and Plans to Create a Special Dividend Reinvestment Plan 4
    (Date:7/24/2014)... can be reduced by enabling patients to see the ... This is just one of several recommendations made in ... University of Bristol. , Called ,Primary care factors and ... report has been compiled by researchers from the University,s ... from studies around the world. They found that patients ...
    (Date:7/24/2014)... to nicotine, known as neonicotinoids, were found commonly ... new USGS study. This is the first broad-scale ... States and one of the first conducted within ... broad range of insect pests, use of neonicotinoid ... across the United States, particularly in the Midwest. ...
    (Date:7/24/2014)... Becker's Hospital Review has published the 2014 ... With Great Oncology Programs." Organizations on this year's list ... care, cancer outcomes and research. , The Becker's Hospital ... rankings and awards they have received from a variety ... part of the criteria for inclusion on the list: ...
    (Date:7/24/2014)... 24, 2014 The European Omega 3 & ... & structured lipids market in Europe with analysis and forecast ... $670.37 million in 2012 to $989.91 million by 2018, at ... through the TOC of the European omega 3 & structured ... analysis provided. This also provides a glimpse of the segmentation ...
    (Date:7/24/2014)... July 24, 2014 The European air and ... in 2014, and is expected to register a CAGR of ... Germany, Russia, and turkey are the major spenders in the ... medium extended air defense program and multinational (MEADS) program, which ... Browse through the TOC of the Europe air and missile ...
    Breaking Medicine News(10 mins):Health News:Seeing the same GP at every visit will reduce emergency department attendance 2Health News:Corn & soy insecticides similar to nicotine found widespread in Midwest rivers -- USGS news 2Health News:100 Hospitals, Health Systems With Great Oncology Programs 2Health News:100 Hospitals, Health Systems With Great Oncology Programs 3Health News:100 Hospitals, Health Systems With Great Oncology Programs 4Health News:Europe Omega 3 & Structured Lipids (Nutraceuticals) Market is Expected to Reach $989.91 Million in 2018 - New Report by MicroMarket Monitor 2Health News:Europe Omega 3 & Structured Lipids (Nutraceuticals) Market is Expected to Reach $989.91 Million in 2018 - New Report by MicroMarket Monitor 3Health News:Europe Omega 3 & Structured Lipids (Nutraceuticals) Market is Expected to Reach $989.91 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Europe Air and Missile Defense Radar Market is Expected to Reach $2.07 billion in 2020 - New Report by MicroMarket Monitor 2Health News:Europe Air and Missile Defense Radar Market is Expected to Reach $2.07 billion in 2020 - New Report by MicroMarket Monitor 3Health News:Europe Air and Missile Defense Radar Market is Expected to Reach $2.07 billion in 2020 - New Report by MicroMarket Monitor 4
    ... Physical Activity, Weight Control, and Breast Cancer Risk , ... randomized controlled trials that test the impact of physical ... There are substantial observational data suggesting that regular physical ... a reduction in breast cancer risk: however, it is ...
    ... concerned workers, navigating quarantine barriers and liabilities are ... epidemic-wary managersNEW YORK, April 28 Business managers ... government advisories should prepare to handle difficult legal ... pandemic scenario, says New York litigation partner Kenneth ...
    ... Acetaminophen, NSAIDs can cause liver or stomach illness ... 28 (HealthDay News) -- Many over-the-counter painkillers and ... on the potential danger of liver damage and ... Manufacturers will have to include these warnings on ...
    ... a statement of Debra L. Ness, President National Partnership for ... able to quickly bring the swine flu outbreak under control ... But that will happen more quickly if people can follow ... are trying to contain this potential pandemic. Unfortunately, in ...
    ... DATATRAK International, Inc. (Nasdaq: DATA ), ... solutions for the clinical trials industry, today reported that ... the newest member of the DATATRAK CRO Connect Program(TM). ... CROs, CPI is able to expand its electronic data ...
    ... State today issued an alert recommending that American citizens ... due to a recent outbreak of Swine Flu. While ... evolve, InsureMyTrip.com is reminding travelers of the ... http://www.newscom.com/cgi-bin/prnh/20070529/NETU076LOGO )"Right ...
    Cached Medicine News:Health News:JNCI April 28 tip sheet 2Health News:JNCI April 28 tip sheet 3Health News:JNCI April 28 tip sheet 4Health News:Swine Flu Plans Triggering Difficult Legal Questions, Says Noted Pillsbury Attorney 2Health News:Swine Flu Plans Triggering Difficult Legal Questions, Says Noted Pillsbury Attorney 3Health News:FDA Adds New Label Warnings to Over-the-Counter Painkillers 2Health News:Stay Home with Swine Flu Symptoms? Not Without Paid Sick Days 2Health News:German CRO clinicalprojects international GmbH Becomes Newest Member of DATATRAK's CRO Connect Program(TM) 2Health News:German CRO clinicalprojects international GmbH Becomes Newest Member of DATATRAK's CRO Connect Program(TM) 3Health News:German CRO clinicalprojects international GmbH Becomes Newest Member of DATATRAK's CRO Connect Program(TM) 4Health News:InsureMyTrip.com Informs Travelers of Insurance Companies Response to Swine Flu 2Health News:InsureMyTrip.com Informs Travelers of Insurance Companies Response to Swine Flu 3Health News:InsureMyTrip.com Informs Travelers of Insurance Companies Response to Swine Flu 4Health News:InsureMyTrip.com Informs Travelers of Insurance Companies Response to Swine Flu 5Health News:InsureMyTrip.com Informs Travelers of Insurance Companies Response to Swine Flu 6
    Fiber optic illumination with XHL xenon halogen illumination. Large-diameter glass viewing window with 3X magnification, airtight window seal and swivelling viewing window....
    Compact format, fiber optic illumination for uniform reflection-free light. Polycarbonate housing with chrome-plated cone....
    Sleek, all-metal head with large-diameter viewing window. 3X magnification....
    Provides bright output and rotating lens with ultra-seal for pneumatic otoscopy....
    Medicine Products: